This test is most useful if any of these apply to you.
Cortisone changes across the day, which makes collection time part of its interpretation. A midday result is an exploratory measurement. Its usefulness for diagnosing chronic stress, assessing recovery, or guiding preventive treatment has not been established. Research on salivary cortisone supports studying daily patterns, but does not establish a healthy midday target for you.
The catalog lists this result in ng/mL but does not specify the specimen or measurement method. Those details need confirmation before applying saliva research to your result. Blood, saliva, urine, and hair measurements reflect different aspects of hormone production and processing.
Your adrenal glands release cortisol. Enzymes in your tissues convert it into cortisone and can convert cortisone back into cortisol. Conversion to cortisone in the kidney helps keep cortisol from activating receptors that control salt retention and blood pressure. Conversion back to cortisol in tissues such as the liver, fat, and brain increases local exposure to the active hormone. These processes mean that a cortisone concentration reflects hormone processing as well as cortisol availability.
Saliva has a particular relationship to cortisol. Cortisol that is free of blood carrier proteins enters the salivary glands, where much of it becomes cortisone. Human studies found that salivary cortisone closely follows free blood cortisol and is usually more concentrated than salivary cortisol. This evidence concerns saliva and cannot automatically be applied to a test whose specimen is unspecified.
For people who sleep at night, cortisol generally rises around waking and falls toward bedtime. The decline includes shorter pulses, so it is not a smooth slide. Salivary cortisone also follows a daily pattern. Several timed measurements can describe that pattern more fully than one midday value, although describing a pattern does not establish its cause or whether changing it would improve your health.
A small study found less day-to-day variation in salivary cortisone than in salivary cortisol after waking. It studied morning samples, so it does not establish that midday cortisone is a more reliable marker for long-term tracking.
Most evidence connecting daily hormone patterns with health concerns salivary cortisol, a different measurement. In about 4,000 British civil servants, a flatter morning-to-evening cortisol decline was associated with more cardiovascular deaths. A study of 250 people undergoing heart bypass surgery also linked a flatter preoperative cortisol curve with subsequent cardiac events or death. These were observational findings, so they do not show that changing the curve prevents those outcomes.
A meta-analysis linked flatter cortisol slopes with several measures of poorer mental and physical health. The strongest association was with immune and inflammatory outcomes, though the average association across outcomes was small. These findings help explain the research interest in daily hormone patterns; they do not validate midday cortisone as an individual risk score.
Research measuring cortisone itself has also found a cardiovascular association, but in hair. In the Dutch Lifelines cohort, hair cortisone was available for about 4,700 participants and higher concentrations were associated with subsequent cardiovascular disease, particularly in younger adults. Hair reflects exposure over months. That finding cannot be translated into the meaning of a timed midday concentration.
Studies of other specimens add context without supplying a target for this test. Higher morning blood cortisol was associated with cardiovascular disease; the genetic analysis supported the same direction but was too imprecise to establish causation on its own. Higher 24-hour urinary cortisol was associated with cardiovascular death in older adults. A separate study linked lower daily salivary cortisol output with later changes in cardiovascular risk factors, rather than demonstrating more heart attacks. These different measurements and outcomes do not establish that either raising or lowering midday cortisone is beneficial.
Cushing's syndrome develops after prolonged exposure to excessive glucocorticoid activity. It can result from the body's own cortisol production or from steroid medicines. Sustained excess can cause high blood pressure, diabetes, abdominal weight gain, muscle weakness, bone loss, fractures, mood changes, and increased susceptibility to infection.
Salivary cortisone has shown diagnostic promise when collected late at night or after dexamethasone. Dexamethasone normally suppresses the body's cortisol production. In a study of people with adrenal nodules, salivary cortisone after dexamethasone helped predict the corresponding blood cortisol suppression result. That comparison did not establish the accuracy of an untreated midday sample. Studies of late-night salivary cortisone likewise depend on their collection protocol and laboratory method.
Adrenal nodules can produce modest cortisol excess without the full physical features of Cushing's syndrome. Research has linked higher blood cortisol after dexamethasone with hypertension and diabetes, including among people whose nodules were classified as nonfunctioning. Another cohort linked greater cortisol nonsuppression with higher mortality. These findings concern blood cortisol under a suppression protocol, not midday cortisone.
Adrenal insufficiency means your body cannot supply enough cortisol. Causes include adrenal damage, inadequate signals from the brain, and suppression by steroid medicines. Symptoms can include fatigue, weight loss, low blood pressure, and sometimes low blood sugar. Severe deficiency can cause a life-threatening adrenal crisis. A midday cortisone measurement has not been validated to confirm or exclude this condition.
The stronger cortisone evidence comes from specific saliva protocols. A study of 220 people at increased risk found that a home sample taken immediately on waking could help identify or exclude adrenal insufficiency, while some results still required stimulation testing. Another study evaluated saliva after an ACTH stimulation test and found useful diagnostic information, with performance depending on the chosen interpretation criteria. Neither study validates a routine midday sample.
Kidney disease can change cortisol clearance and its conversion into cortisone. Studies using blood and urine have found shifts toward a higher cortisol-to-cortisone ratio as kidney function declines. Whether those changes themselves explain excess mortality in kidney disease remains uncertain. A midday cortisone value cannot establish kidney enzyme activity or explain the cause of high blood pressure.
Salivary cortisone varies within the same person across days. In a study of 20 healthy volunteers, the amount of variation depended on collection time. Its estimates do not justify a universal rule that a change must approach a doubling to matter. The study also did not establish that personal trends outperform validated diagnostic testing.
Repeated measurements can describe how your results vary under a consistent protocol. They do not establish that a change reflects better health or that a flat pattern identifies sleep problems, chronic stress, or excessive training. Studies estimating cortisol exposure from salivary cortisone support research use of timed profiles; they do not show that routine serial midday testing improves clinical outcomes.
Evidence-backed interventions that affect your Cortisone (SX Mid-Day) level
Cortisone (SX Mid-Day) is best interpreted alongside these tests.